Genetics

A recent metabolome-wide Mendelian randomization study provides new insight into the possible causal role of circulating metabolites in multiple sclerosis. By integrating large-scale genetic data from blood metabolome GWAS datasets with multiple sclerosis GWAS data, the study prioritized 29 metabolites that may influence disease susceptibility, including serine, lysine, acetone, acetoacetate, uridine, and several lipoprotein-associated lipid fractions. These findings highlight lipid, amino acid, nucleotide, and energy metabolism as biologically relevant pathways in multiple sclerosis pathogenesis, while also emphasizing the need for further experimental and clinical validation before these metabolites can be considered diagnostic biomarkers or therapeutic targets.